Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.

Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.
复制标题

DOI:
10.1038/npp.2009.105
复制
发表时间:
2009-12
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

Abnormal mesolimbic control of cortical cholinergic activity has been hypothesized to contribute to the cognitive symptoms of schizophrenia. Stimulation of NMDA receptors in nucleus accumbens (NAC) increases acetylcholine (ACh) release in prefrontal cortex (PFC), an activation thought to contribute to attentional processing. Thus, the effects of intra-NAC perfusion of NMDA (250–400 μM) on ACh release in PFC were determined in rats receiving lesions of the ventral hippocampus (VH) as neonates (nVHLX), a neurodevelopmental model of schizophrenia, or as adults (aVHLX). NMDA elevated ACh release (100–150% of baseline) in adults sham-lesioned as neonates or in aVHLX rats. Adult nVHLX were unresponsive to NAC NMDA receptor stimulation. The inability of nVHLX to respond to NMDA emerged over development as a separate experiment demonstrated that evoked ACh release was normal prior to puberty (100–150% increase) yet, in these same nVHLX animals, absent after puberty. Amphetamine-evoked ACh release was assessed in nVHLX animals to exclude potential limitations in release capacity. Amphetamine produced greater increases in ACh release than in shams, indicating that nVHLX does not impair the capacity of cholinergic neurons to release ACh. Finally, the ability of 13 days of pretreatment with clozapine (1.25 mg/kg/day) to reinstate NMDA-evoked cortical ACh efflux was determined. Clozapine treatment normalized NMDA-evoked ACh release in nVHLX animals. These experiments reveal that mesolimbic regulation of cortical ACh release is disrupted in post-pubertal nVHLX rats and normalized by low-dose treatment of clozapine; supporting the usefulness of nVHLX animals for research on the neuronal mechanisms underlying the cognitive symptoms of schizophrenia.
DOI: 10.1093/cercor/bhi079
发表时间: 2006-01-01
期刊: CEREBRAL CORTEX
影响因子: 3.7
作者:
Kozak, R;Bruno, JP;Sarter, M
通讯作者: Sarter, M
DOI: 10.1016/s0006-3223(03)00783-2
发表时间: 2004-01-15
影响因子: 10.6
作者:
Goto, Y;O'Donnell, P
通讯作者: O'Donnell, P
DOI: 10.1002/syn.20593
发表时间: 2009-03-01
期刊: SYNAPSE
影响因子: 2.3
作者:
Gruber, Aaron J.;O'Donnell, Patricio
通讯作者: O'Donnell, Patricio
DOI: 10.1111/j.1460-9568.2008.06029.x
发表时间: 2008-02-01
影响因子: 3.4
作者:
Henny, Pablo;Jones, Barbara E.
通讯作者: Jones, Barbara E.
DOI: 10.1007/s00213-004-1848-0
发表时间: 2004-06-01
期刊: PSYCHOPHARMACOLOGY
影响因子: 3.4
作者:
Braff, DL;Light, GA
通讯作者: Light, GA